Colleen M. Cebulla

41.5k total citations · 1 hit paper
89 papers, 2.4k citations indexed

About

Colleen M. Cebulla is a scholar working on Ophthalmology, Oncology and Molecular Biology. According to data from OpenAlex, Colleen M. Cebulla has authored 89 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Ophthalmology, 32 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Colleen M. Cebulla's work include Ocular Oncology and Treatments (42 papers), Retinal Development and Disorders (11 papers) and Cutaneous Melanoma Detection and Management (10 papers). Colleen M. Cebulla is often cited by papers focused on Ocular Oncology and Treatments (42 papers), Retinal Development and Disorders (11 papers) and Cutaneous Melanoma Detection and Management (10 papers). Colleen M. Cebulla collaborates with scholars based in United States, Egypt and United Kingdom. Colleen M. Cebulla's co-authors include Mohamed H. Abdel‐Rahman, Robert Pilarski, Frederick H. Davidorf, James B. Massengill, Karan Rai, Getachew Boru, Daniel D. Sedmak, Benjamin Christopher, Martine J. Jager and Richard D. Carvajal and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Colleen M. Cebulla

82 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uveal melanoma

2020 495 citations Colleen M. Cebulla, Mohamed H. Abdel‐Rahman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colleen M. Cebulla United States	26	1.3k	966	685	502	330	89	2.4k
Nicole Groß United States	30	1.5k 1.2×	969 1.0×	653 1.0×	724 1.4×	427 1.3×	76	3.6k
Elisha Roberson United States	17	1.0k 0.8×	1.4k 1.4×	590 0.9×	838 1.7×	198 0.6×	29	2.8k
Gregorius P. M. Luyten Netherlands	32	2.2k 1.7×	957 1.0×	946 1.4×	885 1.8×	205 0.6×	114	3.0k
Igor Dolgalev United States	25	623 0.5×	1.7k 1.7×	1.1k 1.6×	637 1.3×	425 1.3×	55	3.2k
Nagesh Rao United States	26	231 0.2×	1.3k 1.4×	400 0.6×	304 0.6×	309 0.9×	74	2.3k
O. A. Jensen Denmark	23	1.2k 0.9×	645 0.7×	514 0.8×	166 0.3×	153 0.5×	109	2.0k
Karen Buchkovich United States	11	762 0.6×	1.9k 1.9×	2.2k 3.2×	389 0.8×	145 0.4×	14	3.5k
Tanya Tolmachova United Kingdom	27	641 0.5×	2.8k 2.9×	121 0.2×	839 1.7×	99 0.3×	42	3.9k
Arne Bakker Netherlands	23	141 0.1×	542 0.6×	620 0.9×	945 1.9×	90 0.3×	30	1.9k
Annie Huang Canada	35	99 0.1×	2.3k 2.3×	377 0.6×	203 0.4×	541 1.6×	127	3.8k

Countries citing papers authored by Colleen M. Cebulla

Since Specialization

Citations

This map shows the geographic impact of Colleen M. Cebulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen M. Cebulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen M. Cebulla more than expected).

Fields of papers citing papers by Colleen M. Cebulla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen M. Cebulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen M. Cebulla. The network helps show where Colleen M. Cebulla may publish in the future.

Co-authorship network of co-authors of Colleen M. Cebulla

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen M. Cebulla. A scholar is included among the top collaborators of Colleen M. Cebulla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen M. Cebulla. Colleen M. Cebulla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kittaneh, Muaiad, et al.. (2025). An overview of BAP1 biological functions and current therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(2). 189267–189267. 1 indexed citations

Núñez, Fernando M., et al.. (2025). Exceptional Response of Therapy-Resistant SF3B1 Mutant Conjunctival Melanoma to Nivolumab/LAG3 Inhibitor Relatlimab Combination Therapy: A Case Report. Case Reports in Oncology. 18(1). 381–388.

Abdel‐Rahman, Mohamed H., Alireza Asadpoure, Colleen M. Cebulla, et al.. (2021). A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration. Journal of Personalized Medicine. 11(10). 1031–1031. 23 indexed citations

Massengill, James B., et al.. (2021). BAP1 status and response to radiation in melanoma. Investigative Ophthalmology & Visual Science. 62(8). 2872–2872. 1 indexed citations

Choi, Stacey S., Elaine M. Wells-Gray, Heping Xu, et al.. (2019). Adaptive Optics OCT-Based Drusen Grading for Assessing Severity of Dry Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 60(9). 3465–3465. 1 indexed citations

Binkley, Elaine M., Dimosthenis Mantopoulos, Matthew Ohr, et al.. (2019). Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(8). 1771–1781. 30 indexed citations

Abdel‐Rahman, Mohamed H., Leili Shahriyari, James B. Massengill, et al.. (2018). Identification of novel targeted therapies for BAP1 mutated tumors. Investigative Ophthalmology & Visual Science. 59(9). 4958–4958. 1 indexed citations

Kim, Bongsu, et al.. (2018). A new multichannel method quantitating TUNEL in detached photoreceptor nuclei. Experimental Eye Research. 176. 121–129. 8 indexed citations

Kendra, Kari, et al.. (2017). Ocular side effects of novel and traditional chemotherapeutic agents. Investigative Ophthalmology & Visual Science. 58(8). 5166–5166.

10.

Binkley, Elaine M., et al.. (2016). Ocular side effects of traditional chemotherapeutics and small molecule inhibitors. Investigative Ophthalmology & Visual Science. 57(12). 299–299.

11.

Boru, Getachew, et al.. (2016). Mechanisms of somatic biallelic inactivation of BAP1 in uveal melanoma. Investigative Ophthalmology & Visual Science. 57(12). 5895–5895. 1 indexed citations

12.

Ferguson, Robert, Matjaž Vogelsang, Karan Rai, et al.. (2016). Genetic markers of pigmentation are novel risk loci for uveal melanoma. Scientific Reports. 6(1). 31191–31191. 30 indexed citations

13.

Mantopoulos, Dimosthenis & Colleen M. Cebulla. (2015). Multimodal Imaging of Spontaneously Shifting Primary Vitreoretinal Lymphoma. Ocular Oncology and Pathology. 1(4). 237–240. 14 indexed citations

14.

Mantopoulos, Dimosthenis, et al.. (2015). Bilateral optic neuropathy following bite from brown recluse spider (Loxosceles reclusa). Cutaneous and Ocular Toxicology. 35(2). 1–5. 3 indexed citations

15.

Mantopoulos, Dimosthenis, Kari Kendra, Alan D. Letson, & Colleen M. Cebulla. (2015). Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma. JAMA Ophthalmology. 133(8). 965–965. 48 indexed citations

16.

Tarabishy, Ahmad B., et al.. (2013). Optos fundus imaging in patients with keratoprosthesis. Investigative Ophthalmology & Visual Science. 54(15). 3594–3594.

17.

Abdel‐Rahman, Mohamed H., et al.. (2011). Monosomy 3 Status of Metastatic Uveal Melanomas is Associated with Rapidly Aggressive, Therapy-Resistant Tumors. Investigative Ophthalmology & Visual Science. 52(14). 5383–5383. 1 indexed citations

18.

Cebulla, Colleen M., Maria-Elena Jockovich, Abigail S. Hackam, et al.. (2008). Basic Fibroblast Growth Factor Impact on Retinoblastoma Progression and Survival. Investigative Ophthalmology & Visual Science. 49(12). 5215–5215. 11 indexed citations

19.

Murray, Timothy G., et al.. (2007). Targeting the Tumor Microenvironment as a Therapeutic Strategy for Retinoblastoma. Investigative Ophthalmology & Visual Science. 48(13). 1585–1585. 1 indexed citations

20.

Miller, Daniel M., Colleen M. Cebulla, & Daniel D. Sedmak. (2002). Human Cytomegalovirus Inhibition of Major Histocompatibility Complex Transcription and Interferon Signal Transduction. Current topics in microbiology and immunology. 269. 153–170. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact